Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page history now shows a new revision entry v3.3.4 and removes v3.3.3, which is a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T02:58:24.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 has been added to the record history. The items HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the record history.
    Difference
    0.2%
    Check dated 2025-12-24T13:50:21.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new history revision (v3.3.2) was added and the previous revision (v3.2.0) was removed from the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Funding-status notice at the top of the page was removed and replaced with the standard government-disclaimer banner; no core trial data or functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:15:49.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Record History now reflects updates to the Study Status and Recruitment Status, and notes changes to Locations and Contacts for the NCT04678466 Flotetuzumab Expanded Access Program.
    Difference
    0.1%
    Check dated 2025-11-03T21:20:16.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Significant changes: added a government operating-status notice and updated to v3.2.0; removed the previous v3.1.0 revision tag. Overall, the page now communicates current operating status and a new version.
    Difference
    13%
    Check dated 2025-10-06T06:58:44.000Z thumbnail image

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.